跳至主要内容
临床试验/NCT02036177
NCT02036177已完成4 期

A Prospective, Randomized, Single Blind, Two Arms Controlled Study to Confirm the Safety and Verify Performance of the IUB™ SCu300A Intrauterine Device in Comparison to TCu380 IUD Intra-uterine Contraceptive Device

Ocon Medical Ltd.2 个研究点 分布在 2 个国家目标入组 366 人开始时间: 2014年6月12日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
366
试验地点
2
主要终点
Pregnancy rate

研究概览

简要总结

The novel SCu300A IUB™ (hereafter IUB™) will be evaluated for safety and effectiveness in comparison with a market approved standard T shaped IUD containing 380sq.mm. of copper.

The Primary Endpoints for comparison are based on the objective and subjective parameters.

The objective parameters are pregnancy rate, perforation, expulsion and mal -position rates, changes in the endometrial thickness, rate of complications such as infection and anemia and discontinuation rates after 2 years.

The subjective parameters including Quality of Life (QoL) are: pain during insertion, menstrual characteristics and pain, bleeding in correlation to the bleeding pattern prior to insertion.

The Secondary Endpoints are physician opinion (ease of use in insertion and removal) and subject satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

SCu300A IUB

Experimental

干预措施: SCu300A IUB intrauterine device (Device)

T380A copper IUD

Active Comparator

干预措施: T380A IUD (Device)

结局指标

主要结局

Pregnancy rate

时间窗: 24 months

Safety issues

时间窗: 24 months

Perforations, expulsions, mal-position etc

Patient experience

时间窗: 24 months

Recording of menstrual cramping, pain and bleeding irregularities during the trial period

Discontinuation rate

时间窗: 24 months

次要结局

  • Physician opinion(24 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Multivariate Assessment of the IUB Intrauterine... | 临床试验